Account wins from the 03/06/07 news brief

Share this article:
Natrel Communications has been chosen by Oscient Pharmaceuticals as agency of record for Antara (fenofibrate capsules). Antara is indicated to reduce elevated LDL-C, total-C, triglycerides, and apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia and for treatment of adult patients with hypertriglyceridemia. Oscient Pharmaceuticals is based in Waltham, MA.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions